Updates on capivasertib, belzutifan, talquetamab, & durvalumab
Jun 18, 2026 - 00:19:32
Radio and PodcastLive Radio & PodcastsLoading episode
Fetching episode details...
Radio and PodcastLive Radio & PodcastsRadio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & PodcastsThe EV-303 trial that led to the FDA approval of perioperative enfortumab vedotin + pembrolizumab in cisplatin-ineligible bladder cancer patients in now published in NEJM. We discuss the results and ponder potential futu...
Perioperative Enortumab vedotin + Pembrolizumab is an episode from OncoPharm by OncoPharmPod. The EV-303 trial that led to the FDA approval of perioperative enfortumab vedotin + pembrolizumab in cisplatin-ineligible bladder cancer patients...
This episode belongs to OncoPharm.
Use the player on this page to stream the episode online.
Published Feb 19, 2026, 00:16:30 long, audio available.
Continue listening to more episodes from OncoPharm.
Jun 18, 2026 - 00:19:32
Jun 11, 2026 - 00:25:38
May 28, 2026 - 00:13:49
May 21, 2026 - 00:13:45
May 14, 2026 - 00:09:59
May 7, 2026 - 00:11:35
Apr 30, 2026 - 00:12:41
Apr 23, 2026 - 00:13:56